272 related articles for article (PubMed ID: 25890061)
61. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
Mejia-Vilet JM; Zhang XL; Cruz C; Cano-Verduzco ML; Shapiro JP; Nagaraja HN; Morales-Buenrostro LE; Rovin BH
J Am Soc Nephrol; 2020 Jun; 31(6):1335-1347. PubMed ID: 32300067
[TBL] [Abstract][Full Text] [Related]
62. [Urinary soluble intercellular adhesion molecule-1 and vascular cellular adhesion molecule-1: potential biomarkers of active lupus nephritis].
Wu C; Yang M; Zhou Z; Feng X; Zhong X; Cui S; Wu L; Cao W
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1272-6, 1282. PubMed ID: 26403737
[TBL] [Abstract][Full Text] [Related]
63. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
64. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
Salem MN; Taha HA; Abd El-Fattah El-Feqi M; Eesa NN; Mohamed RA
Z Rheumatol; 2018 Feb; 77(1):71-77. PubMed ID: 27619369
[TBL] [Abstract][Full Text] [Related]
65. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients.
Rosa RF; Takei K; Araújo NC; Loduca SM; Szajubok JC; Chahade WH
J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263
[TBL] [Abstract][Full Text] [Related]
66. Significance of M2 macrophages in glomerulonephritis with crescents.
Li J; Yu YF; Liu CH; Wang CM
Pathol Res Pract; 2017 Sep; 213(9):1215-1220. PubMed ID: 28554749
[TBL] [Abstract][Full Text] [Related]
67. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
Xing Q; Su H; Cui J; Wang B
Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
[TBL] [Abstract][Full Text] [Related]
68. Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis.
Kitagawa A; Tsuboi N; Yokoe Y; Katsuno T; Ikeuchi H; Kajiyama H; Endo N; Sawa Y; Suwa J; Sugiyama Y; Hachiya A; Mimura T; Hiromura K; Maruyama S
Kidney Int; 2019 Mar; 95(3):680-692. PubMed ID: 30712924
[TBL] [Abstract][Full Text] [Related]
69. [Osteopontin in systemic lupus erythematosus].
Kitagori K; Yoshifuji H
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):118-123. PubMed ID: 28603202
[TBL] [Abstract][Full Text] [Related]
70. [Expression and significance of PD-1 on CD4(+); and CD8(+); T cells from the peripheral blood of patients with systemic lupus erythematosus].
Wang Y; Xie C; Sun M; Chai J; Zhou Y; Chen Y; Tang J; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):962-5. PubMed ID: 24011159
[TBL] [Abstract][Full Text] [Related]
71. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
[TBL] [Abstract][Full Text] [Related]
72. Urinary MCP-1 as a biomarker for lupus nephritis: a meta-analysis.
Lee YH; Song GG
Z Rheumatol; 2017 May; 76(4):357-363. PubMed ID: 27278779
[TBL] [Abstract][Full Text] [Related]
73. Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis.
Schwartz N; Michaelson JS; Putterman C
Ann N Y Acad Sci; 2007 Aug; 1109():265-74. PubMed ID: 17785315
[TBL] [Abstract][Full Text] [Related]
74. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.
Sfikakis PP; Boletis JN; Lionaki S; Vigklis V; Fragiadaki KG; Iniotaki A; Moutsopoulos HM
Arthritis Rheum; 2005 Feb; 52(2):501-13. PubMed ID: 15693003
[TBL] [Abstract][Full Text] [Related]
75. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
76. Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury.
Hotta O; Yusa N; Ooyama M; Unno K; Furuta T; Taguma Y
Kidney Int; 1999 May; 55(5):1927-34. PubMed ID: 10231456
[TBL] [Abstract][Full Text] [Related]
77. Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.
Alzawawy A; Zohary M; Ablordiny M; Eldalie M
Int J Rheum Dis; 2009 Dec; 12(4):311-8. PubMed ID: 20374368
[TBL] [Abstract][Full Text] [Related]
78. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
Gupta R; Yadav A; Aggarwal A
Clin Rheumatol; 2021 Mar; 40(3):941-948. PubMed ID: 32809146
[TBL] [Abstract][Full Text] [Related]
79. Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis.
Hanaoka M; Gono T; Kawaguchi Y; Uchida K; Koseki Y; Katsumata Y; Kaneko H; Takagi K; Ichida H; Nitta K; Yamanaka H
Rheumatology (Oxford); 2013 Dec; 52(12):2149-57. PubMed ID: 23463805
[TBL] [Abstract][Full Text] [Related]
80. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
ElGendi SS; El-Sherif WT
Egypt J Immunol; 2009; 16(1):135-48. PubMed ID: 20726330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
